Wednesday, 26 August 2026European Markets

ADOCIA Stock Was 12.47% Up Today

Loading stream...

(vianews) - the market ended the session with adocia (adoc.pa) jumping 12.47% to €4.60 on monday, following the last session's upward trend. cac 40 fell 0.07% to €7,427.31, after four sequential sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

adocia's last close was €4.09, 26.96% under its 52-week high of €5.60.

about adocia

adocia sa, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. its proprietary biochaperone technological platform provides molecular delivery of therapeutic proteins. the company's clinical product pipeline includes insulin formulations, such as biochaperone lispro u100 and u200, which are ultra-rapid formulations based on rapid insulin lispro; biochaperone combo, a combination of acting insulin glargine and rapid-acting insulin lispro; biochaperone lispram, a combination of prandial insulin with pramlintide; and biochaperone glucagon, an aqueous formulation of human glucagon for the treatment of hypoglycemia, as well as m1pram, a metabolite of insulin glargine and pramlintide. its preclinical pipeline includes products for the treatment of diabetes and obesity comprising adoshell islets, an implant containing islets of langerhans; adoral sema, an oral delivery of semaglutide; and biochaperone gluexe, a combination of glucagon and exenatide. the company has a strategic alliance with tonghua dongbao pharmaceutical co., ltd. to develop and commercialize biochaperone lispro and biochaperone combo in china and other asian and middle eastern territories. adocia sa was incorporated in 2005 and is headquartered in lyon, france.

earnings per share

as for profitability, adocia has a trailing twelve months eps of €-0.89.

volume

today's last reported volume for adocia is 257880 which is 221.07% above its average volume of 80317.

volatility

adocia's last week, last month's, and last quarter's current intraday variation average was 1.34%, 0.36%, and 4.41%.

adocia's highest amplitude of average volatility was 4.80% (last week), 5.78% (last month), and 4.41% (last quarter).

more news about adocia (adoc.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com